期刊文献+

冠心病患者载脂蛋白E基因多态性及其与血脂的关系 被引量:6

Relation between apoliprotein E (apoE) gene polymorphisms in patients with coronary heart disease (CHD) and serum lipids
下载PDF
导出
摘要 目的通过研究冠心病患者apoE基因多态性及其与血脂的关系,探讨冠心病的遗传易感因素。方法选取80例冠心病患者,60例健康人,通过聚合酶链反应-限制性片段长度多态性测定apoE基因多态性。结果CHD组携带E3/4基因型较对照组增高,对照组携带E3/3基因型较CHD组增高(P<0.05)。E4等位基因频率分布CHD组明显高于对照组(P<0.05)。CHD组中TG、LDL-C血浓度较对照组增高,E3/4和E3/3基因型较E2/3基因型血中TG、LDL-C增高更明显(P<0.05)。结论apoEE4等位基因可能是冠心病的遗传易感因子,不同的基因型可能通过影响血脂而与冠心病发病有关。 [Objective] The study aim is to explore the hereditary susceptibility of people to develop CHD through studying the relationship between apoE gene polymorphisms in patients with CHD and serum lipids. [Methotis] 80 people with CHD were chosen as study group, 60 normal people were chosen as the control group. Polymerase chain reaction-restrlction fragment length polymorphism (PCR-RFLP) was used to detect the apoE gene polymorphisms. [Results] The frequencies of E3/4 genotypes in CHD group were significantly higher than those in control group. The frequencies of E3/3 were lower in CHD group than those in control group. A significant difference was found in E4 allele between two groups (P〈0.05). The serum levels of TG and LDL-C in CHD group were significantly higher than those in control group (P 〈0.05). The serum levels of TG and LDL-C in E3/4 genotypes and E3/3 genotypes were significantly higher than those in E2/3 genotypes (P 〈0.05) in CHD group. [Conclusion] E4 allele is probably the genetic marker of CHD. Apo-e gene affects the CHD maybe through influence of the CHD patients, serum lipids.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2008年第3期364-366,369,共4页 China Journal of Modern Medicine
关键词 载脂蛋白E 冠心病 基因多态性 血脂 apoliprotein E coronary heart disease gene polymorphism serum llpids
  • 相关文献

参考文献8

  • 1PENG DQ, ZHAO SP, NIE S, et al. Gene-gene interaction of PPAR gamma and Apolipoprotein E affects coronary heart disease risk[J]. Int J Cardiol, 2005, 92: 257-265.
  • 2TAN CE, TAI ES, TAN CS, et al. Apolipoprotein E polymorphism and lipid profile in three ethnic groups in the Singapore population[J]. Atherosclerosis, 2003, 170: 253-260.
  • 3MEIGS JB, ORDOVAS JM, CUPPLES LA, et al. Apolipoprotein E isoform polymo rphisms are not associated with insulin resistance: the framingham offspring study[J]. Diabetes Care, 2000, 23: 669-674.
  • 4BRAECK MAN L, DE BACQUER D, ROSSENEU M, et al. Apolipoprotein E polymor phism in middle-aged Belgian men; phenotype distribution and relation to seru m lipids and lipoproteins[J]. Atherosclerosis, 1996, 120: 67-73.
  • 5STEINBERG FM, JONES JH. Apolipoprotein E enhances lipid intake by macrophages in LPL deficiency during pregnancy[J]. J Lipid Res, 1996, 37: 972-984.
  • 6SIEST G, PILLOT T, REGIS-BAILLY A, et al. Apolipoprotein E: An important gene and protein to follow in laboratory medieine[J]. Clin Chem, 1995, 41(8): 1068-1086.
  • 7SttEEHAN D, BENNETT T, CASH MAN K. Apolipoprotein E gene polymorphisms and serum cholesterol in healthy Irish adults: A proposed genetic marker for coronary artery disease risk[J]. J Ned Sei, 2000, 169: 50-54.
  • 8KESANIEMI YA, EHNHOLM C, MIETTINEN TA. Intestinal cholesterol absorption efficiency in man is related to apolipoprorein E phenotype[J]. J Clin Invest, 1997, 80: 578-581.

同被引文献67

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部